Randomized, Assessor-Blinded Trial Comparing Highly Purified Human Menotropin and Recombinant Follicle-Stimulating Hormone in High Responders Undergoing Intracytoplasmic Sperm Injection
(Abstracted from Fertil Steril 2020;114:321–330)
Source: Obstetrical and Gynecological Survey - Category: OBGYN Tags: GYNECOLOGY: INFERTILITY/REPRODUCTIVE TECHNOLOGIES Source Type: research
More News: Hormones | ICSI (Intracytoplasmic Sperm Injection) | Infertility | Men | OBGYN | Reproduction Medicine